Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



BERGER FRANKLIN M Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Oncology Inc.
Txns: Granted 35,000 options to buy @ $1.21, valued at $42.4k
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 35,000 options to buy @ $2.64, valued at $92.4k
06/15/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.
Txns: Granted 12,000 options to buy @ $1.18, valued at $14.2k
01/05/2023 4 BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.
Txns: Sold 25,000 shares @ $3, valued at $75k
Sold 32,000 shares @ $2.9, valued at $92.8k
Sold 50,000 shares @ $2.86, valued at $143k
Sold 50,000 shares @ $2.67, valued at $133.5k
Sold 43,617 shares @ $2.53, valued at $110.4k
Sold 37,889 shares @ $2.41, valued at $91.3k
Sold 34,334 shares @ $2.42, valued at $83.1k
11/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/15/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Sold 25,500 shares @ $5.1503, valued at $131.3k
Sold 16,166 shares @ $5.156, valued at $83.4k
11/14/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 42,881 shares @ $5.83, valued at $250k
11/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Granted 20,000 options to buy @ $2.44, valued at $48.8k
06/21/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Granted 61,264 options to buy @ $6.5, valued at $398.2k
06/17/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 26,000 options to buy @ $4.8, valued at $124.8k
06/10/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.
Txns: Granted 12,000 options to buy @ $2.09, valued at $25.1k
03/22/2022 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 15,000 shares @ $15.96, valued at $239.4k
Bought 45,000 shares @ $17, valued at $765k
Bought 20,000 shares @ $14.77, valued at $295.4k
09/23/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 3,786 shares @ $14.3, valued at $54.1k
09/23/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Exercised 8,896 options to buy @ $5.91, valued at $52.6k
Exercised 8,896 options to buy @ $7.63, valued at $67.9k
Exercised 8,896 options to buy @ $5.6, valued at $49.8k
06/30/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 26,000 options to buy @ $5.59, valued at $145.3k
06/21/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Granted 34,025 options to buy @ $23.39, valued at $795.8k
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Granted 24,000 options to buy @ $15.33, valued at $367.9k
04/27/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Rain Therapeutics Inc.
Txns: Bought 120,000 shares @ $17, valued at $2M
Bought 5,000 shares @ $15.78, valued at $78.9k
Converted 175,939 shares @ $0
Converted 535,601 shares @ $0
Converted 189,998 preferred shares @ $0
Converted 578,397 preferred shares @ $0
04/19/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns: Disposed/sold 5,000 shares @ $38, valued at $190k
Disposed/sold 12,500 options to buy @ $22.15, valued at $276.9k
Disposed/sold 10,000 options to buy @ $29.8, valued at $298k
Disposed/sold 10,000 options to buy @ $17.27, valued at $172.7k
Disposed/sold 15,000 options to buy @ $6.09, valued at $91.4k
Disposed/sold 20,000 options to buy @ $4.14, valued at $82.8k
03/04/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.
Txns: Bought 57,000 shares @ $27, valued at $1.5M
01/11/2021 4 BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.
Txns: Exercised 1,716 options to buy @ $4, valued at $6.9k
Exercised 6,534 options to buy @ $4, valued at $26.1k
Exercised 2,184 options to buy @ $3.81, valued at $8.3k
Exercised 25,000 options to buy @ $3.23, valued at $80.8k
Exercised 6,773 options to buy @ $4.67, valued at $31.6k
Granted 16,500 options to buy @ $7, valued at $115.5k
11/03/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Converted 759,606 shares @ $0
Bought 41,666 shares @ $24, valued at $1000k
Converted 400,000 convertible preferred @ $0
Converted 132,014 convertible preferred @ $0
Converted 131,578 convertible preferred @ $0
Converted 60,540 convertible preferred @ $0
Converted 35,474 convertible preferred @ $0
10/30/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atea Pharmaceuticals, Inc.
Txns: Granted 80,000 options to buy @ $24, valued at $1.9M
07/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/26/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Granted 8,896 options to buy @ $5.6, valued at $49.8k
06/15/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Atreca, Inc.
Txns: Granted 12,000 options to buy @ $17.87, valued at $214.4k
06/11/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 100,000 shares @ $5.5, valued at $550k
05/15/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns: Granted 20,000 options to buy @ $4.14, valued at $82.8k
02/05/2020 4 BERGER FRANKLIN M (Director) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns: Bought 120,846 shares @ $2.6, valued at $314.2k
12/04/2019 4 BERGER FRANKLIN M (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS, INC.
Txns: Sold 32,090 shares @ $3.92, valued at $125.8k
Sold 47,890 shares @ $4, valued at $191.6k
10/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy